Catalyst Pharmaceuticals, Inc. financial data

Symbol
CPRX on Nasdaq
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 616 % +32.9%
Quick Ratio 18.1 % -13%
Debt-to-equity 14.7 % -13.2%
Return On Equity 26.4 % +2.49%
Return On Assets 23 % +4.5%
Operating Margin 44.8 % +18.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 123M shares +3.05%
Common Stock, Shares, Outstanding 123M shares +3.35%
Entity Public Float 1.72B USD +28.3%
Common Stock, Value, Issued 123K USD +3.36%
Weighted Average Number of Shares Outstanding, Basic 123M shares +3.09%
Weighted Average Number of Shares Outstanding, Diluted 127M shares +1.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 578M USD +25.6%
Research and Development Expense 14.7M USD +35.8%
General and Administrative Expense 56.1M USD +0.3%
Operating Income (Loss) 259M USD +48.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 286M USD +51.4%
Income Tax Expense (Benefit) 68.2M USD +48.4%
Net Income (Loss) Attributable to Parent 218M USD +52.4%
Earnings Per Share, Basic 1 USD/shares +44.4%
Earnings Per Share, Diluted 1 USD/shares +43.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 690M USD +56%
Accounts Receivable, after Allowance for Credit Loss, Current 106M USD +82.6%
Inventory, Net 28M USD +40%
Assets, Current 852M USD +58.2%
Deferred Income Tax Assets, Net 48.3M USD -0.45%
Property, Plant and Equipment, Net 1.08M USD -22%
Operating Lease, Right-of-Use Asset 2.01M USD -12.6%
Assets 1.05B USD +36.2%
Accounts Payable, Current 9.1M USD -21.3%
Employee-related Liabilities, Current 10.6M USD +31.9%
Accrued Liabilities, Current 120M USD +27.5%
Liabilities, Current 129M USD +22.1%
Operating Lease, Liability, Noncurrent 2.46M USD -14.8%
Other Liabilities, Noncurrent 161K USD -94.2%
Liabilities 131M USD +18.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) 447M USD +94.9%
Stockholders' Equity Attributable to Parent 920M USD +39.2%
Liabilities and Equity 1.05B USD +36.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 60M USD +88.1%
Net Cash Provided by (Used in) Financing Activities 3.06M USD -97.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 123M shares +3.35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 690M USD +56%
Interest Paid, Excluding Capitalized Interest, Operating Activities 103K USD +58.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 49.1M USD +28%
Operating Lease, Liability 2.89M USD -12%
Depreciation 115K USD +33.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 218M USD +52.4%
Lessee, Operating Lease, Liability, to be Paid 3.29M USD -14%
Operating Lease, Liability, Current 428K USD +8.91%
Lessee, Operating Lease, Liability, to be Paid, Year Two 570K USD +3.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 553K USD +2.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 396K USD -26.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 587K USD +2.98%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 605K USD +3.07%
Operating Lease, Payments 132K USD +2.33%
Additional Paid in Capital 473M USD +9.67%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9.35M USD +0.01%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%